Multiple Chinese pharmaceutical firms withdraw IPO applications amid enhanced anti-corruption efforts
Multiple Chinese pharmaceutical companies have recently withdrawn their applications for a listing on the A-share market amid the nation’s strengthened efforts to tackle corruption in the medical sector, according to media reports.